P2.04-84 NSCLC Survival Expectancy for Patients Treated with Docetaxel/Nintedanib in the SENECA Trial and Previous Immunotherapy
- Resource Type
- Source
- Journal of Thoracic Oncology. 14:S742-S743
- Subject
Pulmonary and Respiratory Medicine Expectancy theory Oncology medicine.medical_specialty business.industry medicine.medical_treatment Immunotherapy chemistry.chemical_compound chemistry Docetaxel Internal medicine medicine Nintedanib business medicine.drug - Language
- ISSN
- 1556-0864